IGM Biosciences Inc. (IGMS)
1.16
-0.08 (-6.45%)
At close: Mar 31, 2025, 3:59 PM
1.15
-0.36%
After-hours: Mar 31, 2025, 05:34 PM EDT
IGM Biosciences Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 26.5M | 112.52M | 121.23M | 133.33M | 241.08M | 35.89M | 1.89M | 432K |
Short-Term Investments | 157.29M | 225.16M | 305.93M | 96.21M | 125.19M | 188.74M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 11.97M | 100K | 50K |
Other Long-Term Assets | 1.06M | 1.81M | 2M | 1.04M | 548K | 258K | n/a | 8K |
Receivables | n/a | n/a | n/a | n/a | n/a | 35K | 35K | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | -11.97M | n/a | n/a |
Other Current Assets | 9.83M | 9.92M | 21.33M | 11.21M | 14.01M | 6.43M | 485K | 223K |
Total Current Assets | 193.62M | 347.6M | 438.42M | 240.75M | 373.27M | 231.1M | 2.41M | 655K |
Property-Plant & Equipment | 71.03M | 74M | 73.08M | 56.34M | 34.81M | 18.02M | 1.47M | 677K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 72.09M | 75.81M | 75.08M | 57.38M | 35.36M | 30.25M | 1.57M | 735K |
Total Assets | 265.71M | 423.41M | 513.5M | 298.13M | 408.63M | 261.35M | 3.98M | 1.39M |
Account Payables | 983K | 1.33M | 2.51M | 5.58M | 7.92M | 3.09M | 164K | 225K |
Deferred Revenue | 2.65M | 3.78M | 148.93M | n/a | n/a | n/a | 3.69M | 116K |
Short-Term Debt | 7.12M | 5.83M | 11.63M | 6.64M | 5.33M | 4.97M | 8.32M | n/a |
Other Current Liabilities | 26.88M | 31.54M | 27.8M | 15.56M | 3.98M | 822K | 3.59M | 507K |
Total Current Liabilities | 37.64M | 42.48M | 44.69M | 27.78M | 17.24M | 8.88M | 8.89M | 976K |
Long-Term Debt | 38.06M | 34.67M | 35.36M | 25.44M | 9.58M | 12.24M | n/a | n/a |
Other Long-Term Liabilities | 141.84M | n/a | n/a | n/a | n/a | n/a | 60.92M | 40.79M |
Total Long-Term Liabilities | 179.9M | 177.7M | 181.55M | 25.44M | 9.58M | 12.24M | 60.92M | 40.92M |
Total Liabilities | 217.54M | 220.18M | 226.24M | 53.22M | 26.82M | 21.12M | 69.81M | 41.89M |
Total Debt | 45.19M | 40.51M | 41.17M | 28.76M | 12.24M | 14.73M | 5.03M | n/a |
Common Stock | 342K | 586K | 431K | 325K | 319K | 304K | 4K | 4K |
Retained Earnings | -1.02B | -821.24M | -574.83M | -353.72M | -188.56M | -107.2M | -64.07M | -41.36M |
Comprehensive Income | 159K | 151K | -701K | -66K | 26K | 43K | -667K | -389K |
Shareholders Equity | 48.17M | 203.23M | -574.83M | -353.72M | -188.56M | -107.2M | -65.83M | -40.5M |
Total Investments | 157.29M | 225.16M | 305.93M | 96.21M | 125.19M | 200.72M | 100K | 50K |